The world now has more people aged 65 and over than children under 5—but America is actually getting younger relative to the rest of the globe

The U.S. ranked the 48th-oldest of 227 countries in 2025 but is projected to become relatively younger, falling to 110th by 2060 as other regions age faster. Aging nevertheless raises U.S. fiscal, labor-force and healthcare challenges: the share of healthy years after age 60 fell 2 percentage points from 2000 to 2019, while 73% of Americans over 65 had at least two chronic conditions in 2016-19. Health and social-care employment is already benefiting from demographic demand, adding an average 32,000 jobs per month over the past year.

Analysis

The investable implication is less a near-term demand shock than a persistent mix shift toward labor-intensive care delivery, where reimbursement rarely keeps pace with wage inflation. Hospitals and post-acute providers face the most acute margin squeeze because staffing scarcity raises labor costs while Medicare and Medicaid rate resets lag; HCA and THC have better scale to absorb this than smaller operators, while home-health reimbursement remains a key swing factor for AMED and related providers. Medical-device suppliers with chronic-care exposure, including ABT, MDT and BSX, are better positioned to monetize higher treatment intensity without carrying the same labor burden.

The U.S.'s relatively favorable demographic trajectory versus developed-market peers is a medium-term relative-growth and capital-allocation advantage, not an immediate BLK earnings catalyst. Over 6-18 months, slower labor-force and consumption growth in Japan, Korea and parts of Europe should reinforce demand for U.S. liquid assets and retirement products, benefiting asset gatherers with retirement-channel distribution such as BLK and TROW; however, fee compression means flows must translate into higher-margin active, alternatives, or retirement-advice assets to matter for earnings.

Consensus may overstate the inflationary implication of aging while understating fiscal crowd-out. Higher healthcare and transfer spending can steepen the long end if Treasury supply rises faster than domestic savings, but weak aggregate demand and a higher savings propensity among older households offset part of that impulse. The actionable macro variable is therefore not demographics alone but whether healthcare outlays accelerate faster than nominal GDP and force upward revisions to Treasury issuance or entitlement projections over the next budget cycle.

Key Decisions for Investors

• Maintain a 6-18 month quality tilt within healthcare services: long HCA versus short HUM in equal dollar amounts. HCA retains pricing and scale advantages in concentrated local markets, while HUM is more exposed to Medicare Advantage rate and utilization volatility; exit if HCA labor-cost growth exceeds revenue growth for two consecutive quarters or HUM's medical-cost trend materially improves.
• Add a 12-18 month basket of ABT, BSX and MDT on broad healthcare weakness rather than chase demographic headlines. These names offer chronic-disease and procedure-volume exposure with lower direct labor sensitivity; use a 10-12% downside stop or reassess on adverse Medicare device reimbursement changes.
• Treat BLK as a watch item, not a demographic-driven entry: initiate only if retirement and alternatives net inflows accelerate while fee realization stabilizes. The thesis is falsified if industry fee pressure offsets AUM growth, leaving organic base-fee growth below low-single digits despite favorable market levels.
• Monitor the next U.S. budget and Treasury refunding cycle for upward long-duration supply revisions; if term premium rises alongside healthcare-spending forecast revisions, express via a modest 3-6 month TLT put spread rather than an outright duration short. Do not position solely on population data absent confirmation in issuance guidance and long-end auction tails.